Opioid and benzodiazepine requirements in neonatal and pediatric patients undergoing venoarterial ECMO: insights from a predominantly cardiac cohort - Scorecard - MDSpire
Advertisement
Sedation and Analgesic Use of Opioids and Benzodiazepines in Neonates and Children on Venoarterial ECMO: Findings from a Primarily Cardiac Patient Group
Clinical Scorecard: Sedation and Analgesic Use of Opioids and Benzodiazepines in Neonates and Children on Venoarterial ECMO: Findings from a Primarily Cardiac Patient Group
At a Glance
Category
Detail
Condition
Sedation and analgesia management in neonates and pediatric patients on ECMO
Key Mechanisms
Altered pharmacokinetics, prolonged critical illness, need for deep sedation
Target Population
Neonates and pediatric patients aged ≤14 years on venoarterial ECMO
Care Setting
Pediatric cardiac surgical intensive care unit
Key Highlights
80 patients included, with 68.8% having postoperative cardiac disease
Median cumulative opioid exposure: 7.33 mg/kg; benzodiazepine exposure: 15.75 mg/kg
Prolonged ICU stay and ECMO duration linked to higher opioid exposure
Higher average opioid doses and acute kidney injury associated with increased in-hospital mortality
Need for individualized sedation strategies and structured weaning approaches
Guideline-Based Recommendations
Diagnosis
Identify clinical predictors of sedative and analgesic dose requirements
Management
Utilize individualized sedation strategies to optimize outcomes
Monitoring & Follow-up
Monitor cumulative opioid and benzodiazepine exposure during ECMO
Risks
Be aware of risks associated with oversedation, drug accumulation, and iatrogenic withdrawal
Patient & Prescribing Data
Neonates and pediatric patients on venoarterial ECMO
High reliance on opioids and benzodiazepines, with adjunctive agents considered
Clinical Best Practices
Implement goal-directed sedation strategies to reduce opioid exposure
Consider pharmacokinetic changes in ECMO patients when prescribing sedatives
Evaluate the need for adjunctive sedative agents to limit cumulative exposure
by Somayah A. Alsuhaibani, Ashjan F. Alghanem, Ibrahim A. Alredaini, Shaimaa Alsulami, Luluah A. AlTukhaifi, Reem M. Beheri, Mashael AlFaifi, Renad A. Alshuraim, Lama Alfehaid, Khalid Al Sulaiman
